Analysis of incidence and prevalence of the respiratory system diseases of the adult population of Moscow and the Russian Federation

Introduction. As a result of the COVID-19 pandemic that swept whole world in 2020, level and structure morbidity changed, “center gravity” adult mortality shifted towards infectious diseases. The anti-epidemic reorientation healthcare systems has had negative impact on health patients with non-communicable diseases (NCDs). result, population, particular respiratory related to most important NCDs, becomes particularly relevant conditions epidemiological restrictions Moscow spread increased burden Healthcare system Moscow. Purpose. purpose this study is analysis indicators incidence prevalence population Russian Federation for periods 2015–2019 2019–2020. Methods materials. used data official statistics Ministry Health “Morbidity population” (incidence by care seeking data) 2015–2020, ICD-10 chapter X “Diseases system” (J00-J99), blocks “Chronic lower diseases” (J40-J47): Asthma, Status asthmaticus (J45, J46); Other chronic obstructive pulmonary disease (J44); bronchitis, Emphysema (J40-J43). Results. continue occupy leading positions Federation. In accounted 16.8 % (in 2015 – 15.1 %), which than 17.7 (2015 13.8 %). was 33.8% 33.5 Federation, amounting 36.9 28.2 2020 20 830.8 per 100 000 19.6 (25 910.0). Over period 2015–2019, indicator tended increase 10.2 %, 6.2 %. For 2019–2020 Moscow, only 5.4 there were higher growth rates (+21.9 15,832.1 1.3 times national average (21,376.0). rate decreased 7.9 6.6 2019–2020, 4.8 general, 29.7 recorded from 2019 during “COVID-19 lockdowns” mainly are high asthma. At same time, decrease bronchitis emphysema registered both Russia. Conclusion. Thus, tends decrease, while increase, requires additional research find cause-and-effect relationships.